Cargando…

Impact of l-Arginine Metabolism on Immune Response and Anticancer Immunotherapy

The progression from neoplastic initiation to malignancy happens in part because of the failure of immune surveillance. Cancer cells successfully escape immune recognition and elimination and create an immune-suppressive microenvironment. A suppressive metabolic microenvironment may also contribute...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Sun-Hee, Roszik, Jason, Grimm, Elizabeth A., Ekmekcioglu, Suhendan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864849/ https://www.ncbi.nlm.nih.gov/pubmed/29616189 http://dx.doi.org/10.3389/fonc.2018.00067

Ejemplares similares

Targeting iNOS to increase efficacy of immunotherapies
por: Ekmekcioglu, Suhendan, et al.
Publicado: (2017)

Editorial: Targeting Metabolism in Cancer Immunotherapy
por: Roszik, Jason, et al.
Publicado: (2018)

iNOS Associates With Poor Survival in Melanoma: A Role for Nitric Oxide in the PI3K-AKT Pathway Stimulation and PTEN S-Nitrosylation
por: Ding, Zhen, et al.
Publicado: (2021)

Cervical Cancer Neoantigen Landscape and Immune Activity is Associated with Human Papillomavirus Master Regulators
por: Qin, Yong, et al.
Publicado: (2017)

Inhibition of Microsomal Prostaglandin E2 Synthase Reduces Collagen Deposition in Melanoma Tumors and May Improve Immunotherapy Efficacy by Reducing T-cell Exhaustion
por: Fukuda, Yasunari, et al.
Publicado: (2023)

The Expression of CD74-Regulated Inflammatory Markers in Stage IV Melanoma: Risk of CNS Metastasis and Patient Survival
por: Ogata, Dai, et al.
Publicado: (2020)

Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma
por: Bailey, Peter, et al.
Publicado: (2016)

Arginine deprivation therapy for malignant melanoma
por: Yoon, Jung-Ki, et al.
Publicado: (2012)

High-Throughput Architecture for Discovering Combination Cancer Therapeutics
por: Gianni, Matt, et al.
Publicado: (2018)

Identification of predictive biomarker signatures in melanoma tumors associated with response to tumor-infiltrating lymphocyte (TIL) therapy
por: Chen, Jie Qing, et al.
Publicado: (2013)

Interplay between soluble CD74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanoma
por: Fukuda, Yasunari, et al.
Publicado: (2022)

Correction: Interplay between soluble CD74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanoma
por: Fukuda, Yasunari, et al.
Publicado: (2022)

Cell Surface CD74-MIF Interactions Drive Melanoma Survival in Response to Interferon-γ
por: Tanese, Keiji, et al.
Publicado: (2015)

Characterization of the Inflammatory Microenvironment and Identification of Potential Therapeutic Targets in Wilms Tumors()()
por: Maturu, Paramahamsa, et al.
Publicado: (2014)

Cancer Immunotherapy and the Immune Response in Follicular Lymphoma
por: Stenner, Frank, et al.
Publicado: (2018)

Cancer Immunotherapy and the Immune Response in Hodgkin Lymphoma
por: Renner, Christoph, et al.
Publicado: (2018)

Targeted Arginine Metabolism Therapy: A Dilemma in Glioma Treatment
por: Hou, Xiaoshuang, et al.
Publicado: (2022)

Metabolic Regulation of Immune Responses to Mycobacterium tuberculosis: A Spotlight on L-Arginine and L-Tryptophan Metabolism
por: Crowther, Rebecca R., et al.
Publicado: (2021)

Platelet Metabolism and Other Targeted Drugs; Potential Impact on Immunotherapy
por: Kanikarla-Marie, Preeti, et al.
Publicado: (2018)

Monitoring Regulatory Immune Responses in Tumor Immunotherapy Clinical Trials
por: Olson, Brian M., et al.
Publicado: (2013)

Supplementation of l‐arginine boosts the therapeutic efficacy of anticancer chemoimmunotherapy
por: Satoh, Yusuke, et al.
Publicado: (2020)

L-Canavanine potentiates the cytotoxicity of doxorubicin and cisplatin in arginine deprived human cancer cells
por: Nurcahyanti, Agustina DR, et al.
Publicado: (2016)

The Role of the Immune Response in Brain Metastases: Novel Imaging Biomarkers for Immunotherapy
por: Zakaria, Rasheed, et al.
Publicado: (2021)

Mechanisms underlying response and resistance to immune checkpoint blockade in cancer immunotherapy
por: Lee, Junghwa, et al.
Publicado: (2023)

Predictive immune biomarker signatures in the tumor microenvironment of melanoma metastases associated with tumor-infiltrating lymphocyte (TIL) therapy
por: Chen, Jieqing, et al.
Publicado: (2014)

Crosstalk between arginine, glutamine, and the branched chain amino acid metabolism in the tumor microenvironment
por: Wetzel, Tanner J., et al.
Publicado: (2023)

Targeting the arginine metabolic brake enhances immunotherapy for leukaemia
por: Mussai, Francis, et al.
Publicado: (2019)

Cardiotoxicity of Contemporary Anticancer Immunotherapy
por: Dal’bo, Natalie, et al.
Publicado: (2020)

Metabolic Modifications, Inflammation, and Cancer Immunotherapy
por: Zheng, Sihao, et al.
Publicado: (2021)

Lipid metabolism in tumor immunology and immunotherapy
por: Duong, Lisa K., et al.
Publicado: (2023)

Assessment of PD-L1 mRNA expression in gastrointestinal tumors and the response to immunotherapy
por: Qiu, Qingqing, et al.
Publicado: (2022)

A molecular classification system for estimating radiotherapy response and anticancer immunity for individual breast cancer patients
por: Zhang, Jiaxuan, et al.
Publicado: (2023)

Independent prognostic biomarker FERMT3 associated with immune infiltration and immunotherapy response in glioma
por: Zhuo, Shenghua, et al.
Publicado: (2023)

Diagnostic biomarker KIF23 is associated with immune infiltration and immunotherapy response in gastric cancer
por: Bai, Maoshu, et al.
Publicado: (2023)

Targeting Epigenetic Processes in Photodynamic Therapy-Induced Anticancer Immunity
por: Wachowska, Malgorzata, et al.
Publicado: (2015)

l-Arginine Supplementation and Metabolism in Asthma
por: Kenyon, Nicholas J., et al.
Publicado: (2011)

Protein Arginine Methylation: An Emerging Modification in Cancer Immunity and Immunotherapy
por: Dai, Weijing, et al.
Publicado: (2022)

Targeting T Cell Metabolism for Improvement of Cancer Immunotherapy
por: Le Bourgeois, Thibault, et al.
Publicado: (2018)

Cellular and Molecular Biomarkers Predictive of Response to Immunotherapy in Acute Myeloid Leukemia
por: Wiatrowski, Kyle, et al.
Publicado: (2022)

Establishment of lactate-metabolism-related signature to predict prognosis and immunotherapy response in patients with colon adenocarcinoma
por: Zou, Zhengrong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hc0heeohg517v4gsumq0bc37pq